Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,025 | 4 | 96.4% |
| Travel and Lodging | $814.98 | 5 | 3.0% |
| Food and Beverage | $157.17 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Development Center Americas, Inc. | $23,052 | 4 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,945 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $3,066 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($3,066) |
| 2017 | $23,931 | 11 | Takeda Development Center Americas, Inc. ($23,052) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,066.00 | General |
| 02/23/2017 | Takeda Development Center Americas, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,854.50 | General |
| 02/22/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $120.00 | General |
| 02/22/2017 | Takeda Development Center Americas, Inc. | — | Travel and Lodging | Cash or cash equivalent | $93.00 | General |
| 02/22/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $22.57 | General |
| 02/22/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 02/21/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $250.00 | General |
| 02/21/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $181.98 | General |
| 02/21/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $170.00 | General |
| 02/21/2017 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $113.43 | General |
| 01/31/2017 | Takeda Development Center Americas, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,052.00 | General |
| 01/31/2017 | Takeda Development Center Americas, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,052.00 | General |
About Dr. Robert Levine, MD
Dr. Robert Levine, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Guilford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1104159037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Levine, MD has received a total of $26,997 in payments from pharmaceutical and medical device companies, with $3,066 received in 2019. These payments were reported across 12 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($26,025).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Guilford, CT
- Active Since 09/10/2009
- Last Updated 09/10/2009
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104159037
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.